Review reframes feline hippocampal necrosis as a shared endpoint: full analysis

A newly published review in The Veterinary Journal is trying to bring sharper definitions to a confusing corner of feline neurology: feline hippocampal necrosis, hippocampal sclerosis, and temporal lobe epilepsy. The authors argue that FHN is not one discrete disease entity, but a histopathologic finding that can arise from several different disease processes, even as it remains closely tied to the clinical syndrome of feline temporal lobe epilepsy. (sciencedirect.com)

That distinction matters because the literature has evolved in layers. A 2000 retrospective study of 38 cats described acute-onset seizures, often progressing to clusters or status epilepticus, with bilateral lesions restricted to the hippocampus and sometimes the piriform lobe, and suggested a structural brain process with an unknown cause, possibly environmental or toxic. Subsequent clinical and experimental reviews helped define a recognizable temporal lobe seizure semiology in cats, including arrest, staring, salivation, licking, lip smacking, facial twitching, chewing, head turning, and eventual generalized convulsions. (academic.oup.com)

More recent work has complicated the picture in useful ways. A 2021 case series and literature review described seven cats with hippocampal and piriform lobe necrosis and emphasized that the syndrome resembles human autoimmune limbic encephalitis and temporal lobe epilepsy. That paper also noted that diagnosis is primarily clinical plus MRI-based, and that affected cats are often refractory to conventional antiseizure treatment. Separately, a 2023 review on temporal lobe epilepsy in cats stressed that feline TLE is best viewed as a seizure syndrome that can arise from many causes, using the familiar “VITAMIN D” framework: vascular, inflammatory, toxic, anomalous, metabolic, idiopathic, neoplastic, and degenerative. (journals.sagepub.com)

The autoimmune angle is one of the biggest shifts in the field. Earlier JVIM work suggested that autoimmune limbic encephalitis likely exists in cats and that VGKC-complex, now better understood in part through LGI1-associated disease, may play an etiologic role in seizure disorders with orofacial involvement. A later Frontiers study went further, describing selective limbic blood-brain barrier breakdown and arguing that this feline syndrome may be a natural counterpart to human LGI1 encephalitis. A 2023 ScienceDirect study of spontaneously occurring autoimmune limbic encephalitis in cats added a larger cohort, reporting LGI1 antibodies in most antibody-positive cases and reinforcing the link between immune-mediated disease and hippocampal injury. (academic.oup.com)

Industry-style commentary has long reflected what clinicians see in practice: these seizures can be distinctive, but not always easy to classify early. A dvm360 report on earlier work from Vienna highlighted that focal seizures not involving the whole body may point toward hippocampal pathology, and that some cats do not respond immediately to therapy. That aligns with the broader literature showing that a subset of cats with temporal lobe phenotypes may worsen quickly, present in clusters, or require extended management and referral-level diagnostics. (dvm360.com)

Why it matters: For veterinarians, the review pushes the field away from shorthand labels and toward more precise thinking. If FHN is a common endpoint rather than a single disease, then “hippocampal necrosis” should trigger a search for cause, not end the diagnostic conversation. In practice, that means recognizing temporal lobe seizure signs, considering MRI when feasible, weighing inflammatory or autoimmune causes alongside neoplasia and vascular injury, and setting expectations with pet parents that standard antiseizure drugs may not fully control disease in every case. It also strengthens the case for pathology and case reporting, because definitions in this area still depend heavily on clinicopathologic correlation. (sciencedirect.com)

There is also a translational dimension. Multiple papers explicitly compare feline temporal lobe epilepsy and hippocampal pathology with human mesial temporal lobe epilepsy and limbic encephalitis. That does not mean the conditions are identical, but it does suggest that feline cases may help refine understanding of seizure propagation, hippocampal injury, and immune-mediated epilepsy across species. For specialty practices and academic centers, that could support more interest in antibody testing, advanced imaging, EEG, and standardized definitions in future studies. (academic.oup.com)

What to watch: The next step is likely not a single breakthrough treatment, but better phenotyping, clearer separation of FHN from hippocampal sclerosis, and more data on which cats have autoimmune disease, which have structural lesions, and which diagnostic findings actually change management. (sciencedirect.com)